ArticleJournal of pharmacy practice2023

A Real-World Comparison of Apixaban and Rivaroxaban in Obese and Morbidly Obese Patients With Nonvalvular Atrial Fibrillation.

Kevin T Burnham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.